Recalls & Warnings December 12, 2018 Seller of Protein Powder, Spirulina & Other Products Warned for Manufacturing Violations On October 31, 2018, the FDA issued a warning letter to DynaPro International, Inc
The reaction was visualized with VECTOR ImmPRESS REAGENT for 30 min and finally incubated with di-aminobenzidine for 5 min
Phase 1b/2a Subcutaneous Formulation (Obesity) Published: The Lancet, June 2025 Participants: 125 adults with overweight or obesity (BMI 27.039.9), aged 1855 Duration: Up to 36 weeks Dosing: Once-weekly subcutaneous amycretin, up to 60 mg Results: - Up to 22% absolute weight loss at 36 weeks (highest dose group) - Placebo-adjusted difference: approximately 24% - No weight-loss plateau observed at study end Safety: 81% of the 89 participants who reported a TEAE had gastrointestinal events
Stop alpha lipoic acid 2 weeks before surgery
Long Reptides Read our full thoughts here: To view or add a comment, sign in Semax LIVE Update Big day for the peptide community
Ethics declarations Author taxonomy FA, PCS, MM Conceptualization